Gonorrhea clinical trials at UCLA

1 research study open to eligible people

Doxycycline Prophylaxis for Prevention of Sexually Transmitted Infections
open to eligible females ages 13-29
The goal of this open-label, randomized trial is to assess the efficacy of doxycycline prophylaxis in reducing incidences of bacterial sexually transmitted infections (STIs) among adolescent and young adult females while also evaluating acceptability and antimicrobial resistance in order to inform public health policy.
Los Angeles, California and other locations

Last updated: October 13, 2026

Doxycycline Prophylaxis for Prevention of Sexually Transmitted Infections